Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Surgery. 2012 Mar;151(3):437-43. doi: 10.1016/j.surg.2011.08.001. Epub 2011 Oct 13.
Primary aldosteronism caused by aldosterone-producing adenoma is the most common curable cause of secondary hypertension, but despite resection, many patients continue to require antihypertensive medications to control their blood pressure postoperatively. The Aldosteronoma Resolution Score is a preoperative 4-item predictive model for the complete postoperative resolution of hypertension. Our aim was to validate the accuracy of this model in predicting postoperative resolution of hypertension in Japanese patients.
The records of 91 Japanese patients who underwent unilateral adrenalectomy for aldosterone-producing adenoma were surveyed retrospectively. Patients were distributed into 2 groups according to whether blood pressure was normal without antihypertensive medications at 6 months postoperatively. Clinical and biochemical data were evaluated at baseline and after the 6-month follow-up.
At 6 months, blood pressure had normalized in 45% of the patients without antihypertensive medications. Multivariate logistic regression analysis revealed that patients who had complete resolution of hypertension were significantly more likely to have been taking ≤2 antihypertensive medications preoperatively, have a duration of hypertension of <6 years, and be female. The predictive accuracy of the Aldosteronoma Resolution Score was assessed using the area under the curve of receiver operator characteristics analysis. The value of the area under the curve was 0.81.
Our external validation revealed that the Aldosteronoma Resolution Score developed using Western data can identify accurately Japanese individuals with aldosterone-producing adenoma who are likely to have complete resolution of hypertension after adrenalectomy.
由醛固酮瘤引起的原发性醛固酮增多症是继发性高血压最常见的可治愈病因,但即使进行了切除,许多患者仍需要降压药物来控制术后血压。醛固酮瘤缓解评分是一种术前 4 项预测模型,可预测高血压术后完全缓解。我们的目的是验证该模型在预测日本患者术后高血压缓解准确性。
回顾性调查了 91 例因醛固酮瘤而行单侧肾上腺切除术的日本患者的记录。根据术后 6 个月是否无需降压药物血压正常,将患者分为两组。在基线和 6 个月随访时评估临床和生化数据。
在 6 个月时,45%的患者无需降压药物血压已正常。多变量逻辑回归分析显示,完全缓解高血压的患者术前更有可能服用≤2 种降压药物,高血压持续时间<6 年,且为女性。使用受试者工作特征曲线下面积评估醛固酮瘤缓解评分的预测准确性。曲线下面积的值为 0.81。
我们的外部验证表明,使用西方数据开发的醛固酮瘤缓解评分可以准确识别出日本醛固酮瘤患者,这些患者在肾上腺切除术后很可能完全缓解高血压。